Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ethanol Sclerotherapy vs Cystectomy for Endometriomas
NCT02472873Unknown
- Sponsor
- Meir Medical Center
- Start
- Jun 2015
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of ethanol in endometrioma (2 arms), sponsored by Meir Medical Center. Primary endpoint: endometrioma recurrence rate at 6 months. Status: unknown.
02
Drugs
ethanol
03
Conditions
endometrioma
Beyond the preview
Go deeper on NCT02472873.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02472873.